...
首页> 外文期刊>Clinical and Experimental Immunology: An Official Journal of the British Society for Immunology >Donor-specific tolerance induction in organ transplantation via mixed splenocytes chimerism
【24h】

Donor-specific tolerance induction in organ transplantation via mixed splenocytes chimerism

机译:混合脾细胞嵌合体在器官移植中诱导供体特异性耐受

获取原文
获取原文并翻译 | 示例
           

摘要

We have shown previously that donor-derived splenocytes can replace recipients' bone marrow and induce donor-specific tolerance (DST). We have also shown the usefulness of the chimeric state for the induction of DST. Further analysis of mixed splenocytes chimera, especially the role of each T cells in mixed splenocytes chimera, is indispensable issue for its clinical use. A chimeric state has been shown to achieve long-term survival in major histocompatibility complex (MHC)-mismatched grafts. The donor-derived splenocytes can replace recipients' bone marrow and induce DST. The long-term survival of allogeneic skin grafts was achieved without immunosuppressants. In this study we show the role of each T cell type in a splenocyte mixed chimera. This review provides a short summary of our original work, adding some supplemental interpretations. Mixed chimerism is thus considered an attractive approach for the induction of DST without the use of immunosuppressants. In this paper, we summarize some of the findings on mixed splenocyte chimeras and review mixed chimerism in recent organ transplantation.
机译:先前我们已经表明,供体来源的脾细胞可以替代受体的骨髓并诱导供体特异性耐受性(DST)。我们还显示了嵌合状态对于诱导DST的有用性。对于混合脾细胞嵌合体的进一步分析,尤其是每个T细胞在混合脾细胞嵌合体中的作用,对于其临床应用是必不可少的问题。嵌合状态已显示在主要组织相容性复合物(MHC)不匹配的移植物中可实现长期生存。供体来源的脾细胞可以取代受体的骨髓并诱导DST。没有免疫抑制剂,就可以实现同种异体皮肤移植的长期存活。在这项研究中,我们显示了每种T细胞类型在脾细胞混合嵌合体中的作用。这篇评论提供了我们原始工作的简短摘要,并添加了一些补充说明。因此,不使用免疫抑制剂,混合嵌合体被认为是诱导DST的有吸引力的方法。在本文中,我们总结了混合脾细胞嵌合体的一些发现,并综述了最近器官移植中的混合嵌合体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号